Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Operating Margin
Below are the top drugs-generic stocks on the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at Hi-Tech Pharmacal Co Inc (NASDAQ: HITK) is 33.13%. HITK's revenue for the same period is $219.97 million.
The trailing-twelve-month operating margin at Salix Pharmaceuticals Ltd (NASDAQ: SLXP) is 25.63%. SLXP's ROE for the same period is 18.41%.
The trailing-twelve-month operating margin at Akorn Inc (NASDAQ: AKRX) is 21.78%. AKRX's PEG ratio is 0.80.
The trailing-twelve-month operating margin at Mylan Inc (NASDAQ: MYL) is 16.95%. MYL's revenue for the same period is $6.03 billion.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Drugs-Generic Industry Highest Operating Margin NASDAQTrading Ideas
